Financial Data and Key Metrics Changes - In the fourth quarter, net income increased by 7% to $87 million or $1.7 per diluted share [7] - For the full year, net income totaled $167.9 million or $3.29 per diluted share [8] - Revenues for the fourth quarter increased by 22% to $670.5 million, while annual revenues grew by 10% to $1.7 billion [8][4] - Book value per share increased by 11% to $34.78, reflecting a 92% increase over the last five years [5][17] Business Line Data and Key Metrics Changes - In the fourth quarter, the company sold 4,891 lots with an average sales price of $115,700, while for the year, 14,240 lots were sold at an average price of $108,400 [8] - The gross profit margin for the fourth quarter was 22.3%, down 160 basis points from the previous year [9] - The pretax income for the fourth quarter increased by 4% to $113.1 million, with a pretax profit margin of 16.9% [10] Market Data and Key Metrics Changes - The company noted slower new home sales due to affordability constraints and cautious consumer sentiment, but builder incentives are helping to bridge the affordability gap [12] - The availability of contractors and materials remains solid, with stable land development costs [12] Company Strategy and Development Direction - The company plans to continue executing its strategic plan by investing for future growth, maximizing returns, and consolidating market share in the lot development industry [6] - Forestar aims to maintain a minimum 15% pretax return on average inventory and a return of initial cash investment within 36 months [15] - The company expects to invest approximately $1.4 billion in land acquisition and development in fiscal 2026 [15] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in long-term demand for finished lots despite near-term headwinds from home affordability constraints [21] - The company anticipates delivering between 14,000 to 15,000 lots and generating $1.6 billion to $1.7 billion in revenue for fiscal 2026 [20] Other Important Information - The company ended the quarter with $968 million in liquidity, including $379 million in unrestricted cash [17] - Total debt was $803 million with no senior note maturities until fiscal 2028, resulting in a net debt to capital ratio of 19.3% [17] Q&A Session Summary Question: Why is growth expected to be in line with Horton? - Management indicated that growth is tied to the size of Horton and their market entry, with the potential for mid-single-digit growth depending on market conditions [25] Question: What is the outlook for headcount and SG&A leverage? - The company expects headcount to remain flat or slightly decrease in fiscal 2026, following a significant increase in fiscal 2025 [26] Question: Are there any pushbacks on lot prices or extended takedown schedules? - Management confirmed successful renegotiation of terms but noted minimal pushback on lot pricing, managing it project by project [29] Question: What trends are observed in Texas and Florida? - Management noted some pressure in Texas and Florida markets but still sees good absorption at affordable price points [32] Question: What is the expected cadence of deliveries in 2026? - The company projects a similar delivery cadence to 2025, with larger deliveries expected in the second half of the year [33]

Financial Data and Key Metrics Changes - The company reported a net income of $621,000 or $0.01 per diluted share for Q3 2025, with core FFO at $26.4 million or $0.31 per diluted share, and AFFO at $28 million or $0.33 per diluted share, reflecting a 3.1% increase year-over-year [10][12] - Total recurring G&A increased to $5.1 million, representing 10.6% of total revenues, down from an 11.1% average last year, indicating improved efficiency [10][12] - The company’s adjusted net debt was $623.5 million, with a pro forma adjusted net debt to annualized adjusted EBITDAre ratio of 3.6 times, below the targeted range of 4.5 to 5.5 times [11][12] Business Line Data and Key Metrics Changes - The company closed $203.9 million in investments across 50 properties at a blended cash yield of 7.4%, with an average lease term of 13.4 years [5][6] - Disposition activity included the sale of 24 properties for $37.8 million at a 7.2% cap rate, allowing reinvestment into higher yielding opportunities [6][12] - The portfolio consisted of 721 investments with 114 tenants across 28 industries, generating over $183 million in ABR [6][7] Market Data and Key Metrics Changes - The company noted that over 62% of its ABR comes from tenants with investment grade ratings, with only 2.7% of ABR expiring through 2027, ensuring stable cash flows [7][12] - The company experienced a decline in its top five tenancy from 28.9% to 22.9% year-to-date, indicating successful diversification efforts [4][6] Company Strategy and Development Direction - The company is increasing its 2025 net investment guidance to a range of $350 million to $400 million, up from $125 million to $175 million, reflecting confidence in market opportunities [4][12] - The focus remains on acquiring high-quality, necessity-based retail properties, with a strategy to maintain a diversified tenant base [9][12] - The company aims to return to normal disposition volumes focused on credit risk and opportunistic sales after a period of elevated activity [6][12] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the current investment landscape, noting it is the most attractive opportunity set seen since going public [9][12] - The company anticipates continued growth in 2026, driven by improved cost of capital and a robust acquisition pipeline [12][54] - Management acknowledged some softness in the lower and middle-income consumer segments but remains focused on resilient sectors [9][12] Other Important Information - The board declared a quarterly cash dividend of $0.215 per share, payable on December 15 to shareholders of record as of December 1 [12] - The company has over $1.1 billion in total liquidity, including cash, available credit, and undrawn term loan capacity [12] Q&A Session Summary Question: Can you elaborate on the attractive opportunity set mentioned? - Management indicated they are focusing on convenience stores, quick service restaurants, and grocery sectors, expecting to maintain a high acquisition pace [16][18] Question: Why didn't the guidance for 2025 AFFO per share change despite high activity? - The timing of investments was heavily weighted towards the end of the quarter, impacting revenue recognition, and there is uncertainty regarding treasury stock dilution [21][22] Question: What are the expectations for investment grade acquisitions? - Management noted a 50 basis point difference in cap rates between investment grade and non-investment grade assets, with a focus on risk-adjusted returns [32][33] Question: How is competition from private equity affecting the company? - Management stated that while there is competition, it primarily targets larger transactions, which do not directly impact the company's strategy [38][39] Question: What is the outlook for cap rates and spreads? - Management expects cap rates to remain stable, with potential slight compression, and believes the current spreads are healthy for future growth [48][50]

Financial Data and Key Metrics Changes - Consolidated EBITDA rose sharply, increasing at a double-digit rate, with significant margin gains driven by cost savings and higher prices [5][6][8] - EBITDA margin expanded by 2.5 percentage points, reaching its highest level for a third quarter since 2020 [7][11] - Free cash flow from operations improved significantly, reaching approximately $540 million, an increase of over $350 million year-over-year [25][26] Business Line Data and Key Metrics Changes - In Mexico, EBITDA grew by 11%, driven by a leaner cost base and higher prices despite lower volumes [16] - The U.S. operations achieved record third-quarter EBITDA and margins, supported by increased cost efficiencies and higher prices [18][19] - The EMEA region saw strong performance, with new records in EBITDA and margins, particularly in Eastern Europe and the Middle East [22][23] Market Data and Key Metrics Changes - Demand conditions in Mexico are showing signs of improvement, with average daily cement sales volume outperforming historical patterns [16] - In the U.S., infrastructure demand remains strong, while residential sector weakness persists [19][52] - The South Central America and Caribbean region posted impressive results, with EBITDA rising by 54% [24] Company Strategy and Development Direction - The company is focused on operational excellence and delivering industry-leading shareholder returns, with a strategic plan aimed at enhancing profitability and free cash flow conversion [4][13] - Project Cutting Edge aims for annualized recurring EBITDA savings of $400 million by 2027, with significant progress already made [11][12] - The company is prioritizing small to mid-size acquisitions in the U.S. and divesting non-core markets to strengthen its position [13][14] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the recovery in demand conditions, particularly in Mexico and the U.S., with expectations for volume growth in 2026 [18][39] - The company anticipates continued improvements in free cash flow conversion and operational efficiency as it progresses with its strategic initiatives [26][29] - Management highlighted the importance of maintaining a disciplined approach to capital allocation while pursuing growth opportunities [13][66] Other Important Information - The company completed the divestment of its operations in Panama and consolidated Couch Aggregates into its U.S. business [2][3][14] - The company is committed to decarbonization efforts, having surpassed the European Cement Association's 2030 CO2 emissions target [6][23] Q&A Session Summary Question: What should we expect for cash conversion next year and 2027? - Management targets around 45% free cash flow conversion from operations in 2026, with further improvements expected beyond that [32] Question: Can we expect a recovery in Mexico's demand volumes? - Management is confident that demand volumes in Mexico should grow by at least 2.5% to 3% next year, driven by infrastructure projects [38] Question: What contributed to the EBITDA margin expansion in Mexico? - The 500 basis points improvement was driven by price increases, reductions in SG&A, and lower variable costs, including energy [42] Question: How does the company view CCUS initiatives? - Management emphasized that CCUS remains a mid-term priority, but will only be pursued if it is accretive to value creation [45][46] Question: What is the outlook for U.S. M&A? - The company is actively looking at family-owned aggregate targets in the U.S. and is strengthening its team for bolt-on acquisitions [73]

Financial Data and Key Metrics Changes - Total revenue growth for the third quarter of 2025 was 9.1%, driven by solid trends outside Mexico and currency tailwinds, particularly in Europe [30] - Operating income increased by 4.3% year over year, reflecting inflationary effects on costs and expenses, partially offset by efficiency efforts [30] - Net consolidated income decreased by 36.8% to 5.8 billion pesos, primarily due to a non-cash foreign exchange loss of 1.3 billion pesos [31][32] Business Line Data and Key Metrics Changes - Proximity Americas reported same-store sales growth of 1.7%, with average ticket rising 4.9% and average traffic contracting 3.1% [19][34] - Total revenues for Proximity Americas grew 9.2%, driven by the expansion of the store network and strong performance in LATAM markets [35] - Operating income for the health division declined by 4%, with same-store sales growing 0.8%, primarily due to strong performance in Chile and Colombia [39][40] Market Data and Key Metrics Changes - In Mexico, OXXO continues to experience a decade of continuous store growth, with a leadership transition to Carlos Arroyo [10] - Coca-Cola FEMSA showed gradual improvement in volume, particularly in South America, despite a slight decline in Mexico [41] - Valora in Europe reported total revenues increased by 10.1% in pesos, driven by higher Swiss retail sales [38] Company Strategy and Development Direction - The FEMSA Forward strategy focuses on maximizing long-term value creation by concentrating on core verticals: retail and beverages, supported by digital initiatives [8] - The company plans to distribute approximately $7.8 billion in capital through dividends and share buybacks between March 2024 and March 2027 [8] - Future growth opportunities are seen in OXXO Brazil, OXXO Colombia, and Bara, with significant potential for value creation [11][26] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the strength of business units despite a sluggish year in Mexico, with positive signs of recovery in traffic and market share gains [9][20] - The company is cautiously optimistic about the upcoming year, anticipating improvements in the operating environment and benefiting from the FIFA World Cup [42] - Management acknowledged challenges from a recent tax increase in Mexico but believes adjustments can be made to maintain return on investment [12] Other Important Information - The company distributed a total of 11.8 billion pesos in dividends during the quarter, with no share buybacks executed [41] - The effective tax rate for the quarter improved to 29.3%, following a spike in the first half of the year [32][33] Q&A Session Summary Question: Insights on same-store sales performance and traffic dynamics at OXXO - Management noted a reversal of trends in OXXO Mexico, with improved traffic performance compared to the first half of the year, and expressed optimism for the fourth quarter [46][49] Question: Details on gross margin performance at OXXO Mexico - Management indicated that gross margin improvements were driven by commercial income growth and a favorable service mix, with expectations for continued gains [54][57] Question: Update on the health business in Mexico and Chile - Management reported strong growth in Chile despite a competitive environment, while acknowledging challenges in Mexico and the need for operational improvements [70][71] Question: Corporate restructuring and SG&A reduction plans - Management discussed ongoing efforts to streamline corporate overhead and indicated potential for significant savings, with further details expected in future calls [78][79] Question: Interest expense increase and its drivers - Management explained that the increase in interest expense was primarily due to lease accounting under IFRS and the consolidation of U.S. operations [95][96]

Financial Data and Key Metrics Changes - In Q3 2025, the company reported net operating revenues of $5.3 billion, with consolidated adjusted EBITDA growing 12% year-over-year to $1.1 billion, resulting in an adjusted EBITDA margin of 20.8%, a 170 basis points improvement from the previous year [5][11] - The company raised its full-year 2025 adjusted EBITDA guidance to a range of $4.47 billion to $4.57 billion, reflecting an increase of $445 million or 11% at the midpoint from initial guidance [7][15] - Free cash flow for Q3 was $778 million, totaling $2.16 billion year-to-date, which is a 22% increase over the same period last year [14] Business Line Data and Key Metrics Changes - The USPI segment generated $492 million in adjusted EBITDA, representing a 12% year-over-year growth, with same-facility revenues increasing by 8.3% [5][11] - The hospital segment's adjusted EBITDA grew 13% to $607 million, with same-store hospital admissions up 1.4% and revenue per adjusted admission increasing by 5.9% [6][12] Market Data and Key Metrics Changes - The company opened a new hospital facility in Port St. Lucie, Florida, aimed at expanding capacity in a rapidly growing area [6] - Exchange business accounted for 8.4% of total admissions and 7% of total consolidated revenues in Q3, showing a slight increase from Q2 [24][77] Company Strategy and Development Direction - The company is focusing on higher acuity services, which has led to improved margins and strong earnings growth [9] - The strategy includes continued M&A and de novo development, with a robust pipeline for future acquisitions [6][9] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the business's performance, citing healthy patient demand and stable operating conditions for 2026 [8][9] - There is uncertainty regarding enhanced premium tax subsidies and their impact on reimbursement and enrollment in exchanges, but management is prepared for various scenarios [8][9] Other Important Information - The company has invested nearly $300 million in M&A activities year-to-date and plans to continue this trend [6] - The company has no significant debt maturities until 2027, providing financial flexibility [14] Q&A Session Summary Question: Q4 guidance and utilization expectations - Management has not built in expectations for higher utilization due to exchange subsidies expiring, and they are confident in their capacity to meet typical demand [19][21] Question: CapEx inputs and allocation - The increase in CapEx is focused on clinical program infrastructure and high-acuity service offerings, with specific investments in cardiac care and surgical programs [26][28] Question: Free cash flow sustainability - Management highlighted improved cash collections and operational efficiencies as key drivers of free cash flow, emphasizing a focus on sustainability [30][32] Question: USPI Q4 guidance and growth - The implied Q4 guidance for USPI suggests year-over-year growth of over 8%, which is consistent with historical trends [35][36] Question: Labor environment and inflationary pressures - The labor environment remains strong, and management does not foresee significant changes or inflationary pressures impacting operations in 2026 [39][41] Question: Conifer's contribution and enrollment capabilities - Conifer is performing well, assisting with patient eligibility and enrollment, and is prepared to support potential changes in exchange enrollment timelines [45][47] Question: Service line performance in Q3 - Growth in USPI was driven by higher acuity services, with a noted recovery in GI services, while respiratory and infectious disease volumes were lower than expected [51][53] Question: DPP contribution and estimates for 2026 - The company recorded approximately $346 million in supplemental Medicaid programs in Q3, with $148 million being prior year adjustments [59][60] Question: Capital allocation and buyback strategy - The company remains active in share repurchases and is responsive to market conditions while continuing to pursue M&A opportunities [62][64] Question: Expense management and AI initiatives - The company is exploring opportunities for cost savings and efficiency improvements, including the use of advanced analytics and automation [66][68] Question: M&A environment for ASCs - The company continues to be a partner of choice in the ASC market, focusing on high-end specialties and maintaining a strong pipeline for growth [71][73]

Financial Data and Key Metrics Changes - Total revenue growth for the third quarter of 2025 was 9.1%, driven by solid trends outside Mexico and currency tailwinds, particularly in Europe [30][31] - Operating income increased by 4.3% year over year, reflecting inflationary effects on costs and expenses, partially offset by efficiency efforts [30][31] - Net consolidated income decreased by 36.8% to 5.8 billion pesos, primarily due to a non-cash foreign exchange loss of 1.3 billion pesos [31][32] Business Line Data and Key Metrics Changes - Proximity Americas' same-store sales increased by 1.7%, with average ticket rising by 4.9% and average traffic contracting by 3.1% [19][34] - Total revenues for Proximity Americas grew by 9.2%, driven by the expansion of the store network and strong performance in LATAM markets [35] - Operating income for the health division declined by 4%, with same-store sales growing by 0.8%, primarily due to strong performance in Chile and Colombia [39][40] Market Data and Key Metrics Changes - In Mexico, OXXO continues to experience sluggish growth, but there are signs of improvement in market share for key categories like beer and snacks [10][20] - Coca-Cola FEMSA showed gradual improvement in volume, particularly in South America, despite a slight decline in Mexico [41] - Valora in Europe reported a 10.1% increase in total revenues, driven by higher retail sales in Switzerland [38] Company Strategy and Development Direction - The company is focused on maximizing long-term value creation through its FEMSA Forward strategy, which includes divesting nearly $11 billion in assets and setting clear capital allocation targets [8][9] - There is a strong emphasis on expanding the OXXO platform in Brazil and Colombia, with significant growth opportunities identified [10][26] - The company aims to enhance its digital capabilities and improve the value proposition of its retail offerings, particularly in coffee and food categories [24][17] Management's Comments on Operating Environment and Future Outlook - Management expressed cautious optimism for the upcoming year, noting signs of improvement in October data and the potential positive impact of the FIFA World Cup [42] - The recent tax increase in Mexico is expected to present challenges, but management believes they can adapt and maintain return on investment [12][30] - The incoming CEO emphasized the importance of urgency and excellence in management to drive future growth [94] Other Important Information - The company distributed a total of 11.8 billion pesos in dividends during the quarter, with no share buybacks executed [41] - The effective tax rate for the quarter improved to 29.3%, following a spike in the first half of the year [32][33] Q&A Session Summary Question: Insights on same-store sales performance and traffic dynamics at OXXO - Management noted a reversal of trends in OXXO Mexico, with improved traffic performance compared to the first half of the year, and expressed optimism for the fourth quarter [46][49] Question: Gross margin performance at OXXO Mexico - Management indicated that gross margin improvements were driven by commercial income growth and a favorable service mix, with expectations for continued gains [54][57] Question: Update on health business in Mexico and Chile - Management reported strong growth in Chile despite a competitive environment, while acknowledging challenges in Mexico and the need for operational improvements [70][71] Question: Corporate restructuring and SG&A reduction - Management discussed ongoing efforts to streamline corporate overhead and indicated potential for significant savings in the future [78][79] Question: Interest expense increase and its drivers - Management explained that the increase in interest expense was primarily due to lease accounting under IFRS and the consolidation of U.S. operations [95][96]

Financial Data and Key Metrics Changes - In Q3 2025, the company reported net operating revenues of $5.3 billion, with consolidated adjusted EBITDA growing 12% year-over-year to $1.1 billion, resulting in an adjusted EBITDA margin of 20.8%, a 170 basis points improvement from the previous year [5][11] - The company raised its full-year 2025 adjusted EBITDA guidance to a range of $4.47 to $4.57 billion, reflecting an increase of $445 million, or 11% at the midpoint from initial guidance [7][15] - Free cash flow for Q3 was $778 million, totaling $2.16 billion year-to-date, which is a 22% increase over the same period last year [14] Business Line Data and Key Metrics Changes - The USPI segment generated $492 million in adjusted EBITDA, representing a 12% year-over-year growth, with same-facility revenues increasing by 8.3% [5][11] - The hospital segment's adjusted EBITDA grew 13% to $607 million, with same-store hospital admissions up 1.4% and revenue per adjusted admission increasing by 5.9% [6][12] Market Data and Key Metrics Changes - The company reported that exchange admissions accounted for 8.4% of total admissions and 7% of total consolidated revenues in Q3, indicating a slight increase from Q2 [24][77] - The company noted that the exchange business at USPI has less exposure compared to the hospital segment, with exchange patients exhibiting consumption patterns similar to Medicaid [22][72] Company Strategy and Development Direction - The company is focusing on higher acuity services, which has led to improved margins and strong earnings growth over the past few years [9] - The strategy includes continued investment in M&A and de novo development, with a robust pipeline for future growth [6][9] - The company plans to invest $875 to $975 million in capital expenditures in 2025, a $150 million increase at the midpoint over prior expectations [7][15] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the business's performance, citing healthy patient demand and stable operating conditions for 2026 [8][9] - There is uncertainty regarding enhanced premium tax subsidies and their impact on reimbursement and enrollment in exchanges, but management is optimistic about a potential compromise [8][21] - The company is committed to maintaining a deleveraged balance sheet and generating strong free cash flow [14][15] Other Important Information - The company recognized a $38 million pre-tax impact for Medicaid supplemental revenues related to prior years in Q3 2025, totaling $148 million year-to-date [13][59] - The company has no significant debt maturities until 2027 and reported $2.98 billion in cash on hand as of September 30, 2025 [14] Q&A Session Summary Question: Q4 guidance and utilization expectations - Management has not built in expectations for higher utilization due to exchange subsidies expiration and is confident in USPI's capacity to handle typical demand [19][21] Question: CapEx inputs and allocation - The increased CapEx is focused on clinical program infrastructure and high-acuity service offerings, with specific investments in cardiac care and surgical programs [26][28] Question: Free cash flow sustainability - Management highlighted improved cash collections and operational efficiencies as key drivers for sustainable free cash flow generation [30][32] Question: USPI Q4 guidance and growth expectations - The implied Q4 guidance reflects typical seasonal growth patterns, with no significant changes in business demand anticipated [35][36] Question: Labor environment and inflationary pressures - The labor environment remains strong, with no significant changes expected, and the company is managing inflationary pressures effectively [39][41] Question: Contribution from Conifer and enrollment services - Conifer is performing well, and the company is preparing to utilize its capabilities for potential enrollment needs if exchange subsidies expire [45][47] Question: Service line performance in Q3 - Growth in USPI was driven by higher acuity services, with some lower-than-expected volumes in respiratory and infectious disease areas noted on the hospital side [51][53] Question: DPP contribution and estimates for the year - The company recorded approximately $346 million in supplemental Medicaid programs in Q3, with $148 million being out-of-period [59][60] Question: Capital allocation and buyback strategy - The company remains focused on M&A and de novo strategies while being active in share repurchases, adjusting based on market conditions [62][64] Question: Expense management opportunities for 2026 - The company is exploring various opportunities for cost savings and efficiency improvements, including labor and supply management [66][68] Question: Impact of the WISER model on USPI - The company is preparing for potential changes in pre-authorization requirements under the WISER model, with a capable revenue cycle function in place [80][81] Question: Inpatient-only list removal impact - The potential removal of the inpatient-only list could benefit the USPI segment, but quantification of the impact is still under discussion [85][86]

Financial Data and Key Metrics Changes - Total revenue growth for the third quarter of 2025 was 9.1%, driven by solid trends outside Mexico and the consolidation of OXXO USA [29] - Operating income increased by 4.3% year over year, reflecting inflationary effects on costs and expenses, partially offset by efficiency efforts [29] - Net consolidated income decreased by 36.8% to 5.8 billion pesos, primarily due to a non-cash foreign exchange loss of 1.3 billion pesos [29][30] Business Line Data and Key Metrics Changes - Proximity Americas reported same-store sales growth of 1.7%, with average ticket rising 4.9% and average traffic declining 3.1% [19][33] - Total revenues for Proximity Americas grew 9.2%, driven by the expansion of the store network by 1,370 stores year on year [34] - OXXO Mexico continues to show strong performance with a decade of continuous store growth and world-class returns on capital [9] Market Data and Key Metrics Changes - In Europe, Valora's total revenues increased by 10.1% in pesos, driven by higher Swiss retail sales [37] - Coca-Cola FEMSA experienced a slight decline in total volume, primarily due to a challenging environment in Mexico, while South America showed resilient performance with volume growth [40] Company Strategy and Development Direction - The company is focused on maximizing long-term value creation through its FEMSA Forward strategy, which includes divesting nearly $11 billion of assets and a capital allocation framework targeting $7.8 billion in capital distribution by 2027 [6][7] - There is a strong emphasis on expanding the OXXO platform in Brazil, Colombia, and the U.S., with significant growth opportunities identified [25][57] - The company aims to enhance its value proposition in food and coffee categories, with ongoing experimentation to launch new offerings [23] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the strength of business units despite a sluggish year in Mexico, highlighting improvements in competitive positions in key categories [8][20] - The company anticipates a better operating environment in Mexico, aided by the FIFA World Cup and improvements in consumption trends [41] - Management acknowledged challenges from a recent tax increase in Mexico but believes adjustments can be made to maintain return on investment [11] Other Important Information - The company distributed a total of 11.8 billion pesos in dividends during the quarter, with no share buybacks executed [40] - The effective tax rate for the quarter was 29.3%, showing improvement from earlier in the year [30] Q&A Session Summary Question: Insights on same-store sales performance and traffic dynamics at OXXO - Management noted a sequential improvement in traffic and market share gains in key categories, with optimism for the fourth quarter [44][46] Question: Details on gross margin performance at OXXO Mexico - Management indicated that gross margin improvements were driven by service mix and pricing strategies, with expectations for continued gains [51][54] Question: Update on health business performance in Mexico and Chile - Management reported strong growth in Chile despite a competitive environment, while acknowledging challenges in Mexico that require operational fixes [61][63] Question: Corporate restructuring and SG&A reduction plans - Management outlined plans for fit-for-purpose initiatives to streamline corporate overhead and achieve significant cost savings [68][70] Question: Increase in interest expense and its drivers - Management explained that the increase in interest expense was primarily due to lease accounting under IFRS and the consolidation of U.S. operations [85]

Financial Data and Key Metrics Changes - In Q3 2025, net operating revenues were $5.3 billion, with consolidated adjusted EBITDA growing 12% year-over-year to $1.1 billion, resulting in an adjusted EBITDA margin of 20.8%, a 170 basis points improvement from the previous year [4][11] - The company raised its full-year 2025 adjusted EBITDA guidance to a range of $4.47 to $4.57 billion, reflecting an increase of $445 million, or 11% at the midpoint from initial guidance [6][14] - Free cash flow for 2025 is now expected to be in the range of $2.275 to $2.525 billion, with free cash flow after non-controlling interest projected at $1.495 to $1.695 billion, an increase of $250 million at the midpoint from previous guidance [7][16] Business Line Data and Key Metrics Changes - USPI's adjusted EBITDA grew 12% year-over-year to $492 million, with same-facility revenues increasing by 8.3% and total joint replacements in ASCs growing by 11% [4][11] - The hospital segment's adjusted EBITDA increased 13% to $607 million, with same-store hospital admissions up 1.4% and revenue per adjusted admission rising 5.9% [5][12] Market Data and Key Metrics Changes - The exchange business represented 8.4% of total admissions and 7% of total consolidated revenues in Q3, with a slight increase in total as a percent of admissions from Q2 [24][68] - The company noted healthy patient demand supporting same-store volume growth and a stable operating environment for 2026 [8][9] Company Strategy and Development Direction - The company is focusing on higher acuity services, which has led to improved margins and strong earnings growth [9][10] - There is a robust M&A and de novo activity, with 11 centers acquired and two new centers opened in Q3, emphasizing high-acuity procedures [5][6] - Capital expenditures for 2025 are expected to be between $875 million and $975 million, reflecting a $150 million increase at the midpoint over prior expectations [6][16] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the business's performance, citing strong same-store revenue growth, high patient acuity, and effective cost controls [11][14] - There is uncertainty regarding enhanced premium tax subsidies and their impact on reimbursement and enrollment in exchanges for 2026, but management remains optimistic about patient demand [8][9] Other Important Information - The company recognized a $38 million pre-tax impact for Medicaid supplemental revenues related to prior years in Q3 2025, totaling $148 million year-to-date [12][54] - The leverage ratio as of September 30 was 2.3 times EBITDA, indicating strong operational performance and financial discipline [13][14] Q&A Session Summary Question: Q4 guidance and utilization expectations - Management has not built in expectations for higher utilization due to exchange subsidies expiring, but they are prepared for typical demand increases in Q4 [19][20] Question: CapEx inputs and allocation - The increased CapEx is focused on clinical program infrastructure and growth strategies, particularly in high-acuity services [25][26] Question: Free cash flow sustainability - The company highlighted improved cash collections and operational efficiencies as key drivers for sustainable free cash flow [28][29] Question: ASC volumes and service line performance - Growth in ASC volumes was driven by higher acuity services, with healthy GI recovery noted in Q3 [46][48] Question: Contribution from DPP in provider taxes - The company recorded approximately $346 million in supplemental Medicaid programs in Q3, with $148 million being out-of-period [52][54] Question: M&A environment for ASCs - The company remains a partner of choice in the ASC market, focusing on high-end specialties and multi-specialty centers [64][66] Question: Impact of CMS WISER model - The company is prepared for changes in pre-authorization requirements and is confident in managing operational adjustments [69][70] Question: Inpatient-only list removal impact - The potential removal of the inpatient-only list could benefit the USPI segment, but quantification of the impact is still under discussion [73][74]

Financial Data and Key Metrics Changes - NAREIT FFO was reported at $0.56 per share for the third quarter, driven by same-property NOI growth of 4% [12] - Base rent growth decreased to a 270 basis point contribution due to a 150 basis point drop in billed occupancy compared to the previous year [12] - The company expects base rent growth to accelerate into 2026 as billed occupancy rebounds [12][15] Business Line Data and Key Metrics Changes - The company executed 1.5 million square feet of new and renewal leases at a blended cash spread of 18% [6] - New leases were signed at a record rate of $2,585 per square foot, with small shop occupancy hitting a record of 91.4% [6][7] - The signed but not yet commenced rent pipeline remains above $60 million, with $22 million of ABR commenced during the quarter [7][13] Market Data and Key Metrics Changes - The percentage of ABR from grocery anchor tenants is now at 82%, with a 35% increase in year-over-year traffic when adding a grocer [9] - The company closed on the $223 million acquisition of LaCenterra at Cinco Ranch, with seven new leases signed or in process [10] Company Strategy and Development Direction - The company continues to focus on executing its business plan, attracting high-quality tenants in a supply-constrained environment [11] - The redevelopment platform is delivering low-risk, compelling returns with several years of runway for future growth [11] - The company is positioned to recycle capital from low-growth assets into those with higher growth potential [11][33] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the leasing environment, noting that the pipeline is higher than a year ago despite signing 10% more in GLA this year [38] - The company anticipates significant tailwinds from 2025 rent commencements and a strong signed but not yet commenced rent pipeline [16] - Management expects lease settlement income to be a headwind to 2026 FFO growth but remains confident in the overall outlook [15][44] Other Important Information - The company announced a 7% increase in its annual dividend to a rate of $1.23, allowing for maximum flexibility in capital allocation [15] - The SEC shelf registration statement is due to expire next month, and a replacement will be filed [14] Q&A Session Summary Question: Factors contributing to same-store NOI growth acceleration in Q4 - Management highlighted the commencement of $22 million of rent in the quarter and an additional $19 million expected to commence between Q3 and Q4 [18][19] Question: Future occupancy levels and reinvestment pipeline - Management noted that there is room for improvement in shop occupancy, with several hundred basis points of potential growth [25][26] Question: Acquisition pipeline and cap rates - Management indicated that the market remains competitive, focusing on value-add opportunities and recycling capital into higher growth assets [30][32] Question: Leasing pipeline and retailer expansion - Management remains optimistic about the leasing environment, with retailers looking to expand despite macro uncertainties [37][38] Question: Tenant health and bad debt expense - Management expressed confidence in tenant credit quality and noted a significant reduction in exposure to at-risk tenants [47][48] Question: Yield expectations for redevelopment projects - Management stated that the average yield for redevelopment projects remains in the high single-digit to low double-digit range, with no changes to their thresholds [71][73] Question: Capital recycling and disposition pipeline - Management emphasized the importance of recycling capital from low-growth assets into those with higher growth potential [83][86]